The Coincidence Between Increasing Age, Immunosuppression, and the Incidence of Patients With Glioblastoma
Published 2019 View Full Article
- Home
- Publications
- Publication Search
- Publication Details
Title
The Coincidence Between Increasing Age, Immunosuppression, and the Incidence of Patients With Glioblastoma
Authors
Keywords
-
Journal
Frontiers in Pharmacology
Volume 10, Issue -, Pages -
Publisher
Frontiers Media SA
Online
2019-03-27
DOI
10.3389/fphar.2019.00200
References
Ask authors/readers for more resources
Related references
Note: Only part of the references are listed.- IDO1 in cancer: a Gemini of immune checkpoints
- (2018) Lijie Zhai et al. Cellular & Molecular Immunology
- IDO1 Inhibition Synergizes with Radiation and PD-1 Blockade to Durably Increase Survival Against Advanced Glioblastoma
- (2018) Erik Ladomersky et al. CLINICAL CANCER RESEARCH
- Age Correlates with Response to Anti-PD1, Reflecting Age-Related Differences in Intratumoral Effector and Regulatory T-Cell Populations
- (2018) Curtis H. Kugel et al. CLINICAL CANCER RESEARCH
- Sequestration of T cells in bone marrow in the setting of glioblastoma and other intracranial tumors
- (2018) Pakawat Chongsathidkiet et al. NATURE MEDICINE
- Effect of Tumor-Treating Fields Plus Maintenance Temozolomide vs Maintenance Temozolomide Alone on Survival in Patients With Glioblastoma
- (2017) Roger Stupp et al. JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION
- Isocitrate dehydrogenase mutations suppress STAT1 and CD8+ T cell accumulation in gliomas
- (2017) Gary Kohanbash et al. JOURNAL OF CLINICAL INVESTIGATION
- Management of glioblastoma in elderly patients
- (2017) Jacob S. Young et al. JOURNAL OF THE NEUROLOGICAL SCIENCES
- Recurrent glioma clinical trial, CheckMate-143: the game is not over yet
- (2017) Anna C. Filley et al. Oncotarget
- Autophagy, Inflammation, and Immunity: A Troika Governing Cancer and Its Treatment
- (2016) Zhenyu Zhong et al. CELL
- Nivolumab alone and nivolumab plus ipilimumab in recurrent small-cell lung cancer (CheckMate 032): a multicentre, open-label, phase 1/2 trial
- (2016) Scott J Antonia et al. LANCET ONCOLOGY
- Men and mice: Relating their ages
- (2016) Sulagna Dutta et al. LIFE SCIENCES
- Advanced age negatively impacts survival in an experimental brain tumor model
- (2016) Erik Ladomersky et al. NEUROSCIENCE LETTERS
- Prognostic and predictive value of tumor-infiltrating lymphocytes for clinical therapeutic research in patients with non-small cell lung cancer
- (2016) Dong-Qiang Zeng et al. Oncotarget
- PD-L1 expression and prognostic impact in glioblastoma
- (2015) Edjah K. Nduom et al. NEURO-ONCOLOGY
- Nivolumab versus Everolimus in Advanced Renal-Cell Carcinoma
- (2015) Robert J. Motzer et al. NEW ENGLAND JOURNAL OF MEDICINE
- Combined Nivolumab and Ipilimumab or Monotherapy in Untreated Melanoma
- (2015) James Larkin et al. NEW ENGLAND JOURNAL OF MEDICINE
- Prognostic value of tumor-infiltrating FoxP3+ regulatory T cells in cancers: a systematic review and meta-analysis
- (2015) Bin Shang et al. Scientific Reports
- Immune Escape Mechanisms as a Guide for Cancer Immunotherapy
- (2014) G. L. Beatty et al. CLINICAL CANCER RESEARCH
- Regulation of immune responses and tolerance: the microRNA perspective
- (2013) Chang-Zheng Chen et al. IMMUNOLOGICAL REVIEWS
- The prognostic value of Foxp3+ tumor-infiltrating lymphocytes in patients with glioblastoma
- (2013) Qi Yue et al. JOURNAL OF NEURO-ONCOLOGY
- Brain dendritic cells: biology and pathology
- (2012) Paul M. D’Agostino et al. ACTA NEUROPATHOLOGICA
- Spleen Cells from Young but Not Old Immunized Mice Eradicate Large Established Cancers
- (2012) K. Schreiber et al. CLINICAL CANCER RESEARCH
- IDO Expression in Brain Tumors Increases the Recruitment of Regulatory T Cells and Negatively Impacts Survival
- (2012) D. A. Wainwright et al. CLINICAL CANCER RESEARCH
- Decline in miR-181a expression with age impairs T cell receptor sensitivity by increasing DUSP6 activity
- (2012) Guangjin Li et al. NATURE MEDICINE
- Glioblastoma survival in the United States before and during the temozolomide era
- (2011) Derek R. Johnson et al. JOURNAL OF NEURO-ONCOLOGY
- Indoleamine 2,3-dioxygenase is a signaling protein in long-term tolerance by dendritic cells
- (2011) Maria T Pallotta et al. NATURE IMMUNOLOGY
- T-cell receptor ligation induces distinct signaling pathways in naive vs. antigen-experienced T cells
- (2011) K. Adachi et al. PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA
- Human bone marrow hematopoietic stem cells are increased in frequency and myeloid-biased with age
- (2011) W. W. Pang et al. PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA
- Ageing is associated with diminished apoptotic cell clearance in vivo
- (2010) T. Aprahamian et al. CLINICAL AND EXPERIMENTAL IMMUNOLOGY
- Accumulation of resident and peripheral dendritic cells in the aging CNS
- (2010) Ulrike W. Kaunzner et al. NEUROBIOLOGY OF AGING
- The immunology of fibrosis: innate and adaptive responses
- (2010) Georg Wick et al. TRENDS IN IMMUNOLOGY
- Expression ofp16INK4ain peripheral blood T-cells is a biomarker of human aging
- (2009) Yan Liu et al. AGING CELL
- Effects of radiotherapy with concomitant and adjuvant temozolomide versus radiotherapy alone on survival in glioblastoma in a randomised phase III study: 5-year analysis of the EORTC-NCIC trial
- (2009) Roger Stupp et al. LANCET ONCOLOGY
- IDH1andIDH2Mutations in Gliomas
- (2009) Hai Yan et al. NEW ENGLAND JOURNAL OF MEDICINE
- CD11c/EYFP transgene illuminates a discrete network of dendritic cells within the embryonic, neonatal, adult, and injured mouse brain
- (2008) Karen Bulloch et al. JOURNAL OF COMPARATIVE NEUROLOGY
- Better Influenza Vaccines for Older People: What Will It Take?
- (2008) Janet E. McElhaney et al. JOURNAL OF INFECTIOUS DISEASES
- Malignant Gliomas in Adults
- (2008) Patrick Y. Wen et al. NEW ENGLAND JOURNAL OF MEDICINE
Find Funding. Review Successful Grants.
Explore over 25,000 new funding opportunities and over 6,000,000 successful grants.
ExploreBecome a Peeref-certified reviewer
The Peeref Institute provides free reviewer training that teaches the core competencies of the academic peer review process.
Get Started